Braingaze, founded in 2013, develops next-generation Mind Tracking Solutions that predict and identify personal behavior for clinical and commercial applications.
The unique method of Braingaze (patented in 44 countries) is based on the predictive power of small eye movements as a marker for cognitive visual processing. We call this eye movement Cognitive Vergence. The Braingaze method is non-invasive, fast and robust, and does not require expensive hardware.
As a first commercial application Braingaze has clinically validated a unique solution to more objectively diagnose ADHD in children and adults.
Varela et al 2018SHOW MORE
World ADHD 2017SHOW MORE
ADPD 2017SHOW MORE
EPA 2017SHOW MORE
Revista Infanto JuvenilSHOW MORE
EPA 2016SHOW MORE
Sole Neuroreport 2016SHOW MORE
Sole et al PloS one 2016SHOW MORE
EPA 2015SHOW MORE
Sole et al PloS one 2015SHOW MORE
Sole et al PloS one 2013bSHOW MORE
Sole et al PloS one 2013aSHOW MORE